NCT03323385View on ClinicalTrials.gov

Evaluation of Preoperative N1539 in Colorectal Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 24, 2017

Primary Completion Date

September 26, 2018

Study Completion Date

September 26, 2018

Conditions
Pain, Postoperative
Interventions
DRUG

N1539

Once Daily

DRUG

Placebo

Once Daily

Trial Locations (10)

19140

Research Center, Philadelphia

33136

Research Center, Miami

33606

Research Center, Tampa

35630

Research Center, Florence

36605

Research Center, Mobile

39202

Research Center, Jackson

43210

Research Center, Columbus

44111

Research Center, Cleveland

44195

Research Center, Cleveland

70006

Research Center, Metairie

Sponsors

Lead Sponsor

Baudax Bio
All Listed Sponsors
lead

Baudax Bio

INDUSTRY

NCT03323385 - Evaluation of Preoperative N1539 in Colorectal Surgery | Biotech Hunter | Biotech Hunter